National
Gay staffers take key roles in Obama campaign
From finance to digital initiatives, supporters working to win second term
[Editor’s note: This is the first of a two-part series.]
Engaging in tasks from fundraising to digital initiatives to public outreach, President Obama’s re-election campaign staff is already hard at work helping to secure a second term in the White House — and many members of the LGBT community have high-profile roles in that effort.
The Washington Blade interviewed four gay and lesbian staffers who are working to re-elect Obama from the campaign headquarters in Chicago. This article is the first in a two-part series and features interviews with two of the campaign workers: Rufus Gifford, the finance director, and Teddy Goff, the digital director.
President Obama’s campaign staff includes several high-profile gay members. (Blade file photo by Michael Key)
For Gifford, who’s gay, seeing Obama serve another two years in office is important because he believes the administration so far has been “two of the most productive years in American history.”
“I’ve been on board with the campaign in one way shape or form since January 2007 — nearly from the moment I met Sen. Obama,” Gifford said. “I was certainly a believer in him and his message and his politics, etc. So, I do believe that the last two years have been two of the very most productive years in American history. In my mind, truly, if we can get four more, think of how much more we can accomplish.”
Gifford said Obama’s accomplishments for the LGBT community — most notably “Don’t Ask, Don’t Tell” repeal — are “obviously very, very personally important” to him. Still, Gifford also counts among the president’s victories passage of the economic stimulus plan and health care reform as well as ratification of the START Treaty, a nuclear-arms reduction agreement.
As finance director, Gifford overseas the funds raised for both the Obama campaign as well as a joint committee that raises funds between the campaign and the Democratic National Committee. It’s similar to his role as finance director of the DNC, which he occupied immediately before joining the Obama campaign, and his role in raising money for Obama in California during the 2008 campaign.
“Every morning I start the day with a 9 a.m. senior staff meeting with the campaign leadership,” Gifford said. “I am a huge believer that finance should never be siloed within a campaign.”
Gifford said he believes the campaign will be stronger and raise more money if he’s talking to the directors of the field department, the digital department, the tech department and the communications department.
In the second quarter, fundraising for the Obama campaign beat expectations. Obama raised more than $86 million for his re-election campaign and the Democratic National Committee, which far outpaced Republican candidates seeking to oust him from the White House.
The third quarter numbers are yet to be made public. Media reports state that the campaign is expecting to rake in less cash because the president had to cancel fundraisers to attend debt ceiling negotiations with congressional leaders.
One difference that Gifford faces working with the Obama campaign in 2012 as opposed to his work in 2008 is the fact that he’s now separated from his partner, Jeremy Bernard, who serves as the White House social secretary.
In 2008, Gifford and Bernard were featured in numerous media outlets as a gay power couple and were named in Out magazine’s listing of the Top 50 power gays.
Gifford declined to comment on his separation from Bernard, but confirmed the couple split in 2009. Gifford’s current partner resides in D.C.
While Gifford manages fundraising for the Obama campaign, another gay member of the president’s re-election team, Goff, handles digital outreach efforts.
As digital director, Goff runs Internet communications for the campaign, which includes outreach via e-mail or social networking sites like Twitter and Facebook.
“Our job in the digital department is to talk to millions of Twitter followers, millions of e-mail subscribers, millions of Facebook fans everyday, and that’s a viewpoint that I think is helpful even in helping shape and inform broader discussions about how we talk to people and how we build,” Goff said.
Goff, who’s 26 and gay, comes to the Obama campaign after his most immediate position working with Blue State Digital, a digital agency in New York. In 2008, Goff ran digital programs at the state level for the Obama campaign.
Goff’s commitment to see Obama re-elected stems from the president’s record over the course of two-and-a-half years in office, which Goff said is “without parallel in my lifetime or even my parents’ lifetime.”
“So for me, he’s every bit as inspiring and compelling a figure as I ever thought he was.”
The main priority for 2011, Goff said, is making sure existing Obama supporters have avenues to make their voices heard.
What’s the best online platform for the Obama campaign to connect with its supporters? Goff said “everybody’s different” in the way they want to interact.
“There may be one person who wants to hear from us via e-mail, and another person who wants to hear from us on Twitter, but our point of view is that isn’t so much what matters,” Goff said. “Most things come and go. This time, four years ago, Myspace was a really big deal. Now people aren’t talking about that so much anymore. The perspective that we try to bring to it is what’s the basic content that’s going to engage people, how can we shape a relationship that’s going to make them feel engaged and feel like a part of the family.”
But the fight to re-elect Obama in 2012 could be more of a challenge than it was making sure he won the White House in 2008. Recent polls have placed Obama’s approval rating at its lowest point during the course of his term. A few weeks ago, Gallup found that Obama’s approval rating was at 39 percent, marking the first time his approval rating had dipped below 40 percent.
Gifford said he’s not in a position to say whether a win for Obama will be more challenging than it was in 2008, but asserted supporters will push on in the effort to claim victory.
Similarly, Goff said he doesn’t know if winning the White House will be more challenging for Obama in 2012, but said he expects the commitment of campaign workers would lead the president to victory.
The support that Obama will receive from the LGBT community in his re-election efforts remains to be seen. Significant milestones in LGBT rights occurred under his watch — most notably the passage of hate crimes legislation and repeal of “Don’t Ask, Don’t Tell.” Obama also received praise earlier this year for dropping the administration’s legal defense of the Defense of Marriage Act in court.
But other actions sought by the LGBT community remain outstanding — such as the enactment of employment protections based on sexual orientation and gender identity. The president’s lack of support for same-sex marriage riles some in the LGBT community as the fight to win marriage equality continues throughout the states.
Gifford said he’d tell anyone who says Obama hasn’t done enough on LGBT issues during his first term in office that “you cannot make the argument that this is not the most pro-gay administration in history.”
How can other LGBT people help who want to see Obama re-elected in 2012? Goff said those who are interested should check out the campaign website or participate in an on-the-ground field program that is being built in communities across the country.
“There are things for people who want to be involved only or primarily in LGBT issues,” Goff said. “We should have LGBT people do that, but also hope that LGBT people will get involved in the broad program and organize their community just like anybody else.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
